Company news
Innate Pharma SA news
Latest news releases, newest first. Pick a year for every news release, call and deck from that year.
Innate Pharma Highlights Abstracts Selected for ASCO 2025 Annual Meeting
May 19, 2025
Innate Pharma Highlights ANKET® Abstracts Selected for the EHA 2025 Congress
May 15, 2025
Innate Pharma Reports First Quarter 2025 Business Update and Financial Results
May 13, 2025
Number of Shares and Voting Rights of Innate Pharma as of May 5, 2025
May 12, 2025
Innate Pharma announces conference call and webcast for Q1 2025 business update
May 6, 2025
Innate Pharma Files Its 2024 Universal Registration Document (Document d’enregistrement universel) and 2024 Annual Report on Form 20-F
April 30, 2025
Innate Pharma Highlights Preclinical Anti-Tumor Efficacy Data of Its Antibody Drug Conjugate IPH4502 at the AACR 2025 Annual Meeting
April 29, 2025
Calls
The 5 newest of 15 calls. Every call is listed under its year.
- Innate Pharma (Euronext:IPH) Q1 2026 Earnings Call
May 13, 2026
Transcript - Innate Pharma (Euronext:IPH) Q4 2025 Earnings Call
Mar 26, 2026
Transcript - Innate Pharma (Euronext:IPH) Q3 2025 Earnings Call
Nov 13, 2025
Transcript - Innate Pharma (Euronext:IPH) Q2 2025 Earnings Call
Sep 17, 2025
Transcript - Innate Pharma (Euronext:IPH) Q1 2025 Earnings Call
May 13, 2025
Transcript
Decks
The 5 newest of 76 decks. Every deck is listed under its year.
- Q2 2026 Earnings Presentation
Earnings · 34 slides · August 2026
- Q1 2026 Earnings Presentation
Earnings · 25 slides · May 13, 2026
- Investor Presentation (May 2026)
Investor deck · 39 slides · May 2026
- Investor Presentation (March 2026)
Investor deck · 40 slides · Mar 26, 2026
- FY2025 Earnings Presentation
Earnings · 28 slides · Mar 26, 2026